Bernard Andruss

Bernard Andruss

Company: Bio-Techne Corporation

Job title: Head, Companion Diagnostics


Dr. Andruss joined in March 2006. Bernard has significant R&D experience from his progressive roles at Ambion, Inc. where he helped initiate new R&D projects and expanded Ambion’s SBIR funding program. He assisted in the spinoff of Asuragen from Ambion and built a sponsored research program that has been awarded over $25M in funding. During his tenure at Asuragen, Bernard was responsible for leading many successful diagnostic product development programs. Prior to Ambion, he worked in progressive roles in academia at Rice University and the University of Texas M. D. Anderson Cancer Center. Dr. Andruss received his Ph.D. in Biochemistry and Cell Biology from Rice University and his B.S. in Biochemistry from Texas A&M University.


Building a Foundation for Successful Companion Diagnostics in an Evolving International Regulatory Landscape 9:40 am

Flexible strategies for global CDx launches to adapt to regulatory, clinical and reimbursement changes Developing a quality, regulatory and clinical framework that anticipates diverse and evolving compliance requirements Preparing for regulatory and quality compliance around novel and emerging technologiesRead more

day: Day 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.